Matt Zamora - Nanalysis Scientific Sales Mang
| NSCIF Stock | USD 0.27 0.01 3.85% |
Insider
Matt Zamora is Sales Mang of Nanalysis Scientific Corp
| Phone | 403 769 9499 |
| Web | https://www.nanalysis.com |
Nanalysis Scientific Management Efficiency
The company has return on total asset (ROA) of (0.0726) % which means that it has lost $0.0726 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.197) %, meaning that it generated substantial loss on money invested by shareholders. Nanalysis Scientific's management efficiency ratios could be used to measure how well Nanalysis Scientific manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Rejji Hayes | Fortive Corp | 46 | |
| Bob Hosler | Keyence | N/A | |
| Padmaprakash Iyer | Trimble | N/A | |
| Catherine Lewis | Garmin | 68 | |
| David Barnes | Trimble | 62 | |
| David Cullin | Teledyne Technologies Incorpora | N/A | |
| Sharmistha Dubey | Fortive Corp | 50 | |
| Wright Lassiter | Fortive Corp | N/A | |
| Read Simmons | Fortive Corp | N/A | |
| Dr Mattera | Coherent | 67 | |
| Ronald JD | Coherent | 64 | |
| Huei Ee | Keysight Technologies | 54 | |
| Sean Biddlecombe | Garmin | N/A | |
| Michelle Holthaus | Keysight Technologies | 47 | |
| Julie Eng | Coherent | 57 | |
| Jonathan Burrell | Garmin | 56 | |
| Kailash Narayanan | Keysight Technologies | 50 | |
| Marie Hattar | Keysight Technologies | 56 | |
| Christopher Koeppen | Coherent | 53 | |
| Kevin Stephens | Keysight Technologies | 58 | |
| Philip Straub | Garmin | 53 | |
Management Performance
| Return On Equity | -0.2 | |||
| Return On Asset | -0.0726 |
Nanalysis Scientific Corp Leadership Team
Elected by the shareholders, the Nanalysis Scientific's board of directors comprises two types of representatives: Nanalysis Scientific inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nanalysis. The board's role is to monitor Nanalysis Scientific's management team and ensure that shareholders' interests are well served. Nanalysis Scientific's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nanalysis Scientific's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Susanne Riegel, Director Mang | ||
| Sean MSc, CEO, Founder | ||
| Julien Muller, Chief Officer | ||
| Greg McFeetors, Head Manufacturing | ||
| Heather Phillips, Director Operations | ||
| Matt Zamora, Sales Mang | ||
| Matthew Selinger, Investor Mang |
Nanalysis Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Nanalysis Scientific a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.2 | |||
| Return On Asset | -0.0726 | |||
| Profit Margin | (0.30) % | |||
| Operating Margin | (0.28) % | |||
| Current Valuation | 52.82 M | |||
| Shares Outstanding | 94.22 M | |||
| Shares Owned By Insiders | 7.37 % | |||
| Shares Owned By Institutions | 0.09 % | |||
| Price To Book | 1.91 X | |||
| Price To Sales | 2.30 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Nanalysis OTC Stock
Nanalysis Scientific financial ratios help investors to determine whether Nanalysis OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanalysis with respect to the benefits of owning Nanalysis Scientific security.